logo
Select company
Select metric
21.31Enterprise Value over Free Cash Flow
VS
Market
49
Sector
56
Industry
43
History
-
$ 12.16Close
$ 5.86 - $ 16.56 52-Week Range
Ticker Information

Ticker

CRMD

Company Name

CORMEDIX INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CORMEDIX INC - Enterprise Value over Free Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CRMD - EV/FCF Historical data
DateEnterprise ValueEnterprise Value over Free Cash FlowFree Cash Flow
6/30/2025$ 648.08M21.31$ 30.41M
3/31/2025$ 691.11M0$ -13.63M
12/31/2024$ 438.3M0$ -50.73M
9/30/2024$ 575.08M0$ -56.15M
6/30/2024$ 246.88M0$ -51.2M
3/31/2024$ 262.7M0$ -45.7M
12/31/2023$ 144.98M0$ -38.74M
9/30/2023$ 118.87M0$ -33.98M
6/30/2023$ 223.19M0$ -31.34M
3/31/2023$ 209.07M0$ -28.24M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CORMEDIX INC's latest trailing twelve months (TTM) EV/FCF stands at 0.
  • Over the past 5 years, CORMEDIX INC's average EV/FCF has been 21.31.
  • The median EV/FCF for CORMEDIX INC during this period was 21.31
  • CORMEDIX INC reached its highest EV/FCF over the past 5 years at 21.31.
  • The lowest EV/FCF recorded by CORMEDIX INC in the same timeframe 21.31

CORMEDIX INC's EV/FCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EV/FCF Benchmarks
CompanyEV/FCF
NAGE : NIAGEN BIOSCIENCE INC 33.05ZYME : ZYMEWORKS INC -ANAB : ANAPTYSBIO INC -PHAT : PHATHOM PHARMACEUTICALS INC -URGN : UROGEN PHARMA LTD -GYRE : GYRE THERAPEUTICS INC 8.82KNRIX : NURIX THERAPEUTICS INC -GERN : GERON CORP -SNDX : SYNDAX PHARMACEUTICALS INC -XNCR : XENCOR INC -

Definition of Enterprise Value over Free Cash Flow

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
EV / FCF
(=) EV/FCF
EV/FCF for CORMEDIX INC is calculated as follows: EV [ $ 139.38M ] / FCF [ $ -19.96M ]
(=) EV/FCF [ 0 ]

CRMD - Enterprise Value over Free Cash Flow, Last 5 years

21.31

Minimum

Jun 30, 2025

21.31

Maximum

Jun 30, 2025

21.31

Average

21.31

Median

EV/FCF Benchmark Analysis

The chart above depicts the distribution of EV/FCF for companies in the Total Stock Market. The average EV/FCF of the companies is 23.46 with a standard deviation of 16.15.
The following table provides additional summary stats:
EV/FCF in the Market:
filtered constituents2.2K
min0.05
max77.98
average23.46
median19.08
std16.15